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ABSTRACT
INTRODUCTION Tobacco smoking among tuberculosis (TB) patients leads to poorer 
treatment outcomes. Smoking cessation support should be integrated into routine 
TB care.  We measured healthcare providers’ fidelity to a smoking cessation 
intervention integrated into routine TB care, in Bangladesh and Pakistan. We 
aimed to understand the role of providers and settings in the implementation of 
behavior support (BS) messages for TB and smoking cessation.   
METHODS The integrated BS intervention was implemented in TB clinics (24 public 
and 1 private). Cross-sectional data were collected on the fidelity of delivery 
of the BS intervention using a predefined fidelity index based on an existing 
validated method of measuring intervention fidelity. Audio-recordings of patient-
provider BS sessions were coded using the fidelity index. Intervention fidelity was 
presented as the proportion of sessions that implemented BS messages. 
RESULTS A total of 96 sessions were conducted, 37 in Bangladesh and 59 in Pakistan. 
In public settings, TB medication advice was offered in 91.9% (95% CI: 78.7–
97.2) of sessions in Bangladesh, and in 75.5% (95% CI: 62.4–85.1) of sessions 
in Pakistan; whilst it was offered in 83.3% (95% CI: 43.7–97.0) of sessions in the 
private setting in Pakistan. Patients’ smoking status was assessed in 70.3% (95% 
CI: 54.2–82.5) of sessions in Bangladesh, and in 34.0% (95% CI: 22.7–47.4) of 
sessions in the public setting and in 66.7% (95% CI: 30.0–90.3) of sessions in 
the private setting in Pakistan. A quit date was set in 32.4% (95% CI: 19.6–48.5) 
of all sessions in Bangladesh, and in 33.3% (95% CI: 9.6–70.0) of all sessions in 
the public setting in Pakistan.
CONCLUSIONS Fidelity to the intended delivery of the intervention was found to be 
high for TB-related messages but not for smoking cessation messages. Clinic 
contexts may play a mediating role in health workers’ opportunities to deliver 
the intervention as planned.
TRIAL REGISTRATION: International Standard Randomized Clinical Trial Number 
(ISRCTN43811467). Registered 23 March 2016, https://doi.org/10.1186/
ISRCTN43811467
ABBREVIATIONS TB: tuberculosis, BCT: behavior change technique, BS: behavior support, DOTS: Directly Observed Treatment 
Short-Term, NTP: National Tuberculosis Control Programme
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Tobacco smoking is a major risk factor for developing 
pulmonary tuberculosis (TB)1, and the ‘dual 
epidemics’ of smoking and TB have led to a high 
burden of disease in South Asian countries2-4. TB 
patients who smoke have poorer treatment outcomes 
than non-smokers, manifesting as slower recovery 
from TB (OR=1.6; 95% CI: 1.0–2.1)5, higher rates 
of treatment failure (OR=2.3; 95% CI: 1.1–4.7)6 and 
higher risk of TB relapse (OR=3.1; 95% CI: 1.6–6.0)7 
and death (OR=2.2; 95% CI: 1.3–3.7)8. Pakistan 
and Bangladesh are among eight countries that 
account for two-thirds of global TB cases9,10. In both 
countries, smoking prevalence is high for men (20% 
daily tobacco use in Pakistan and 35% in Bangladesh 
in 2015)11,12. Targeting smoking cessation through 
behavioral change interventions can be a successful 
strategy to increase quit attempts13. However, 
contextual factors extrinsic to the intervention that 
tend to hinder or bolster its effect14 including training 
and technical support to the providers, are likely to 
influence outcomes15.
TB diagnosed patients are typically requested to 
modify multiple behaviors, such as regularly taking 
medication, making dietary changes, adapting social 
behaviors (e.g. wearing a mask around others or 
not spitting on the ground), and potentially quitting 
smoking. Research on ‘multiple health behavior 
changes’ has gained traction16-18, yet whether these 
changes should be encouraged simultaneously, one 
at a time, or sequentially has not been conclusively 
determined19,20. Integrated strategies of delivering 
several behavioral change components at the same 
time have been found successful in cases of combined 
smoking cessation and physical activity21-23. In low- 
and middle-income countries, several trials have 
shown that interventions for multiple behaviors 
in participants with a pre-existing disease can be 
effectively integrated into routine care24,25. A previous 
trial involving offering behavioral counselling for 
smoking cessation to TB patients in Pakistan proved 
successful26. However, as time is restricted in TB 
clinics, whether such an integrated intervention 
can be successfully implemented by health workers 
requires further examination. A key concern is that 
additional behavioral change messages such as 
smoking cessation may crowd out TB management 
and containment messages.
Another important aspect of successful behavioral 
change relates to the way the intervention is 
delivered. If delivered as intended, interventions 
have the greatest likelihood of realizing the outcomes 
hypothesized to be produced27,28. However, in practice, 
behavioral change interventions are often delivered 
inconsistently29, resulting in increased variability in 
treatment outcomes30,31. To fully capture the extent 
to which different components of an intervention 
are delivered, intervention fidelity assessments 
are recommended within effectiveness studies32,33. 
Intervention fidelity refers to the degree to which an 
intervention is implemented as originally intended34, 
and both the content of the intervention and the 
quality with which it is delivered are important35. 
Measuring intervention fidelity enhances knowledge 
of the intervention components delivered and its 
application in real world settings33. Furthermore, 
understanding delivery of the features of the 
intervention encourages scientific replicability and 
optimizes intervention implementation in practice32,36. 
Optimal delivery of an intervention is subject 
to multiple factors; the so-called ‘potential 
moderators ’ 35,37.  These include part ic ipant 
responsiveness, comprehensiveness of the intervention 
description, strategies to facilitate implementation, 
recruitment, and context37. Choosing a hospital as an 
intervention setting presents a context with special 
processes and microsystems38,39, which can create 
additional barriers to implementation. In routine 
TB care in Pakistan and Bangladesh – our two study 
countries – potential barriers for providing a smoking 
cessation intervention include social acceptability 
of smoking, high healthcare providers’ workload, 
priorities, motivation and capacity to deliver the 
intervention, as well as a lack of training in providing 
support to TB patients40,41. Facilitators for intervention 
delivery by healthcare providers include vocational 
motivation to provide support to patients, knowledge 
of health risks from smoking, and communication 
and rapport-building skills among health workers42. 
Training healthcare providers to deliver an additional 
behavioral change intervention within routine care 
is a promising approach considering pre-established 
trust, authority, access to the intervention recipients 
and knowledge of the additional behavioral changes 
required to best deal with the health condition43,44. 
On the other hand, healthcare providers may not be 
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experts in behavior change techniques (BCT), may 
have limited time and could view the added tasks 
as minor, or as a distraction to their main task of 
providing care38,45. Few studies have assessed the 
effect of healthcare provider training on the delivery 
of different BCTs18. 
Implementation of a standardized intervention 
across settings and countries can vary. Evaluating 
these highly contextual determinants can produce 
insights into the applicability and implementation of 
the intervention46. This study examines the fidelity 
to delivery of a novel multiple behavior change 
intervention addressing both TB and smoking-related 
behaviors in different contexts. It is unclear whether 
fidelity to delivery for a multiple behavior change 
intervention in routine practice can be achieved among 
health workers in the high stress and time scarce 
environment of TB clinics in Pakistan or Bangladesh. 
We explore whether TB care providers can deliver 
smoking cessation messages without compromising 
key TB-related messages such as medication 
adherence. We examine the differences in fidelity 
of delivery and prioritization of certain messages 
across the countries and public/private settings. 
Addressing these knowledge gaps is important to 
facilitate consistent provision of smoking cessation 
to patients with TB in contexts with high burdens 
of lung disease. Therefore, to better understand the 
role of providers and settings in the implementation 
of integrated smoking cessation support, our study 
aimed to achieve the following objectives: 
1. To measure healthcare providers’ fidelity to an 
integrated tobacco cessation intervention delivered 
in routine TB care.
2. To describe differences in delivery of key behavioral 
support messages between Bangladesh and 





A cross-sectional study for fidelity measurement was 
nested within a randomized controlled trial – the 
TB & Tobacco trial – investigating the effectiveness 
of cytisine (a smoking cessation pharmacotherapy) 
when added to BS for achieving smoking abstinence 
among TB patients47. The BS intervention for smoking 
cessation was developed and implemented in routine 
TB care in Bangladesh and Pakistan42. Full details 
of the trial and of the BS intervention are described 
elsewhere42,48. 
Setting
A purposive sample of health centers offering TB 
services in Bangladesh and Pakistan was enrolled (in 
the trial) in consultation with the respective National 
TB Control Programmes (NTP). Health centers were 
selected on the basis that they were functioning, 
designated TB diagnostic centers approved by NTP. 
Out of 32 health centers (17 subdistrict hospitals 
in Bangladesh and 15 secondary care hospitals in 
Pakistan) recruited across both urban and rural areas 
for the trial, 25 centers recorded and reported data 
for the fidelity measurement. 
Pakistan has a plural health system. Therefore, 
when scaling up health interventions, the private 
healthcare settings cannot be ignored. Private sector 
engagement for smoking cessation, however, remains 
an important challenge because of the heterogeneous 
services ranging from formal to informal setups 
spread out in the country. The private sector is 
playing a significant part in health service provision 
in Pakistan, for example, 85% of TB patients initiate 
care seeking in the private setting49,50. It would be a 
missed opportunity by not integrating preventative 
services within these settings. 
Participants 
Participants were TB providers from the sites 
participating in the TB & Tobacco trial. Any DOTS 
provider (including health workers, facilitators, 
or counsellors) involved in the management of TB 
treatment and care for the patients, were eligible for 
inclusion in this study.
Sampling methods 
A convenience sampling approach was taken for audio-
recording sessions between June 2017 and April 
2018. All providers participating in the TB & Tobacco 
study were asked to audio record 3–5 BS sessions 
for the fidelity assessment. Providers self-selected if 
they recorded as well as the day(s) and session(s) 
for their intervention delivery. Written informed 
consent was obtained from providers delivering the 
BS intervention at all trial sites for audio-recording a 
selection of their sessions for fidelity measurement. 
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All recordings sent back to the study team that were 
audible on tape were included in the assessment.
TB patients receiving BS intervention, whose 
sessions were included in the study were requested 
to provide consent verbally prior to the recording 
(opt-in) and study information sheets were handed 
out after the session for patients to sign. Patients were 
given the option to withdraw consent for up to six 
days post-intervention. Ethics approval was obtained 
from the University of York Health Sciences Research 
Governance Committee (Ref: HSRGC/2016/144/B) 
and local ethics committees from Bangladesh (Ref: 
BMRC/NREC/2016–2019/1475) and Pakistan (Ref: 
no. 4–87/16/NBC-200 Part-B/RDC/4197). The 
datasets used and/or analyzed during the current 
study are available from the corresponding author on 
reasonable request. 
Intervention description 
We developed a BS intervention guided by the design 
of prior tobacco cessation interventions in Pakistan26 
and Nepal51. Key messages on the management of 
TB and smoking cessation were delivered to patients 
through flipbooks, leaflets and posters based on 
BCTs. The selection of BCTs for inclusion in our 
smoking counselling intervention were informed by 
focus group discussions as well as interviews with TB 
health workers, NTP staff and national tobacco control 
experts in each country42. The TB messages included 
in the intervention were derived from the counselling 
provided as part of the TB DOTS initiative. These 
messages were a part of standard practice and regularly 
delivered by the health workers. Health workers 
received training on delivering the intervention 
with a special focus on rapport-building with their 
patients. Training lasted 2 days on average, brought 
health workers from several clinics together, and 
included informational sessions and active role-play 
for different counselling scenarios. The intervention 
duration was about  15–20 min. Full details of the 
BS intervention development process, materials and 
reports can be accessed at: https://tbandtobacco.org/.
A health worker guide was given to all participants, 
covering the main topics: 
a) How to deliver the flipbook and leaflet and 
encourage patient engagement.
b) Advice on following the TB medication schedule 
and seeking support from family and friends during 
TB treatment.
c) Evidence for TB and tobacco interaction and health 
risks from smoked and smokeless tobacco.
d) Information on nicotine dependency and its role in 
quit success.
e) Advice for active listening and rapport building 
with different kinds of patients.
f) Advice on how to follow up with patients on their 
tobacco cessation journey42.
Fidelity measure
Index development was guided by the design of two 
previously applied indices for smoking cessation 
among patients with TB in Pakistan52 and smokeless 
tobacco users in Pakistan and the UK53, which were 
adapted for the purpose of this assessment. The 
method employed for quantifying the implementation 
of each intervention component and for developing 
the rating scales, in the fidelity index, has been 
validated in previous studies and found reliable 
(Krippendorff ’s α=0.80, and 0.66) in measuring 
intervention fidelity52. The BCT taxonomy54 was 
used as the coding framework for specifying the 
intervention components for both smoking cessation 
and TB care messages. The index represented two 
domains: adherence to delivery of content-based 
activities of the BS intervention (25 items; 12 TB 
related and 13 smoking cessation related) and quality 
of interaction-based activities (6 items). Each item was 
coded on a 3-point Likert scale (0=not implemented, 
1=partially implemented, and 2=fully implemented) 
(Table 1). Definitions of partial implementation were 
provided for each item. A coding training session was 
developed, and bilingual coders (Urdu and English, or 
Bangla and English) were trained by one researcher 
via online sessions, following the training guidelines 
for the previous successfully conducted fidelity 
studies52. The observer at the private clinic in Pakistan 
was trained by a project researcher who had also 
conducted the training in the public clinics. Audio-
recordings of the patient-provider BS sessions were 
administered by the site researchers. The recordings 
contained no personal identifying information.  
Statistical analysis 
No formal sample size calculation was conducted, 
as the planned analysis was descriptive in nature. In 
Bangladesh, two coders independently coded each 
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audio-recording and discussed differences until a 
decision for a final score was made. In Pakistan, two 
coders independently coded each audio-recording 
and a third researcher independently coded a selected 
sample of audio-recordings for consistency checking 
and validation of the coding process. The subsample 
from the private hospital was coded by one researcher 
directly observing the BS sessions. 
The method used for generating individual items of 
the index and developing corresponding rating scales 
(fully, partially, or not implemented) was adapted 
from previously validated fidelity indices52,53. However, 
because some items in this study included BCTs other 
than those for smoking cessation, it was important to 
test the reliability of the adapted fidelity index. Index 
scores were summarized for each item using mean, 
median and standard deviation, and for each domain 
of the index, i.e. adherence (to delivery of content-
based activities) and quality (of interaction-based 
activities), using mean and standard deviation by 
provider. Inter-coder reliability of the item scores was 
computed using Krippendorff’s alpha, which provides 
a more conservative interpretation of the α coefficient 
than the conventional tests (poor for α<0.67, moderate 
0.67–0.80, and good for α>0.80)53,54. All analyses were 
conducted in SAS version 9.4 (Cary, NC, USA)55.
Fidelity to delivery of the intervention was 
presented as the proportion of patient-provider 
sessions that fully or partially implemented BS 
messages, or did not implement them. 
RESULTS
Ninety-six audio-recordings of intervention sessions, 
37 from 15 public hospital sites in Bangladesh and 
59 from 10 sites in Pakistan (9 public and 1 private 
hospital) were included in the descriptive analysis.  
Description of item and domain scores and 
inter-coder reliability of the fidelity index 
The average fidelity scores for both domains across 
sessions (adherence and quality – maximum scores 
possible were 56 and 10, respectively) are described 
in Table 1. Mean adherence scores ranged between 
2.2 (SD=1.33) and 29.5 (2.08) and mean quality 
scores ranged between 0.0 and 6.3 (1.53). 
The overall mean Krippendorff’s α for individual 
items was 0.548 for adherence to content and 0.357 
for quality of interaction, which indicates poor inter-
coder reliability overall (Table 2). Items 3, 6–8, 12–14 
and 29–31 showed very little variance (Supplementary 
file Table S1). Items 3, 8, 29–31 were found to have 
a floor effect, which means values close to the lowest 
score. Providers did not implement these elements of 
BS in the majority of sessions. 
Adherence to delivery of intervention content 
and quality of interaction 
For Bangladesh, BS messages on TB medication 
and compliance were implemented better than the 












Mean (SD) Mean (SD)
41 2 23.5 (9.19) 5.5 (0.71)
43 3 23.3 (3.21) 2.3 (1.53)
44 3 17.0 (2.00) 3.3 (0.58)
45 3 12.7 (3.06) 3.0 (0.00)
46 3 16.0 (1.73) 5.3 (2.08)
48 3 10.3 (7.57) 5.3 (4.16)
50 3 25.3 (4.04) 5.3 (2.08)
51 3 15.3 (7.02) 4.0 (0.00)
52 3 7.3 (1.15) 2.7 (0.58)
53 1 34.0 (-) 8.0 (-)
54 1 5.0 (-) 3.0 (-)
55 2 9.5 (0.71) 1.5 (2.12)
40 3 14.7 (0.58) 6.3 (1.53)
56 3 13.7 (1.53) 2.0 (1.73)
57 1 13.0 (-) 1.0 (-)
23 5 4.8 (1.64) 0.8 (0.84)
21 5 5.4 (1.67) 0.0 (0.00)
13 5 24.8 (4.44) 1.6 (2.51)
14 4 29.5 (2.08) 1.0 (0.82)
19 5 26.4 (9.61) 1.8 (1.64)
12 5 5.2 (1.92) 0.8 (0.84)
20 4 15.5 (8.74) 4.3 (2.87)
11 5 20.8 (2.39) 0.2 (0.45)
16 5 18.8 (8.17) 1.2 (1.10)
25 4 18.3 (11.32) 0.5 (0.58)
26 6 2.2 (1.33) 0.0 (0.00)
Indus hospital 6 22.7 (4.63) 2.50 (0.55)
Total score for the adherence scale, summarized by provider. Given is the average of 
the number of sessions for a provider, both for the Adherence score and the Quality 
score.
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Figure 1. Study flow chart
Table 2. Item description, mean coder scores for items across sessions, and inter-coder reliability estimates
Item 
number






















Content items TB medication adherence
 1 Provide information about health 
consequences: You can be cured of TB with 
medication
0.67 0.73 0.956 (0.868–1.00) 1.51 1.30 0.617 (0.361–0.872)
 2 Advise or agree on how to perform behavior: 
Keep taking medicines regularly
1.53 1.53 0.943 (0.831–1.00) 1.78 1.62 0.473 (-0.053–0.895)
 3 Advise or agree on how to perform behavior: 
Never take a double dose
0.12 0.07 0.791 (0.791–0.374) 0.03 0.00 0.000 (-1.00–0.000)
 4 Advise or agree on how to perform behavior: 
Keep taking medicine even if they have 
positive or negative effects
0.27 0.33 0.852 (0.630–1.00) 0.38 0.22 0.684 (0.263–1.00)
Content items lifestyle
 5 Advise on, arrange or provide practical help: 
Get help from friends/family not to forget 
medicine
0.75 0.80 0.957 (0.871–1.00) 0.27 0.22 0.875 (0.626–1.00)
Continued
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 6 Advise or agree on how to perform behavior: 
Keep coming to scheduled appointments
0.41 0.38 0.870 (0.717–0.989) 0.19 0.22 0.734 (0.393–0.992)
 7 Advise on, arrange, or provide emotional social 
support: Having TB is not shameful
0.76 0.85 0.913 (0.781–1.00) 0.05 0.22 0.365 (-0.270–1.00)
 8 Advise on, arrange, or provide emotional social 
support: You will need support of family and 
friends to get better
0.04 0.18 0.484 (-0.299–1.00) 0.11 0.11 0.479 (-0.304–1.00)
 9 Advise or agree on how to perform the 
behavior: Encourage the patient to adopt a 
healthy lifestyle
0.96 0.98 0.844 (0.716–0.969) 0.43 0.38 0.580 (0.283–0.847)
 10 Advise or agree on how to perform the 
behavior: Abstain from all tobacco products
0.80 0.80 0.994 (0.981–1.00) 0.27 0.05 -0.074 (-0.968–0.642)
 11 Advise or agree on how to perform the 
behavior: Healthy and nutritious food
1.41 1.45 1.00 (1.00–1.00) 0.86 0.86 0.674 (0.403–0.891)
 12 Advise or agree on how to perform the 
behavior: Getting lots of rest
0.67 0.65 0.952 (0.855–1.00) 0.11 0.11 0.479 (-0.304–1.00)
 13 Advise or agree on how to perform the 
behavior: Getting lots of fresh air
0.78 0.87 0.958 (0.874–1.00) 0.05 0.00 0.000 (-1.00–0.000)
Content items tobacco cessation
 14 Advise or agree on how to perform the 
behavior: Abstaining from alcohol and tobacco
0.49 0.65 0.858 (0.740–0.949) 1.05 0.92 0.371 (-0.079–0.732)
 15 Assess current and past smoking behavior: 
Check if patient uses tobacco
0.71 0.65 1.00 (1.00–1.00) 1.46 1.24 0.513 (0.209–0.979)
 16 Provide information about health consequences 
of performing the behavior: Positive and 
negative effects on TB of quitting tobacco
0.73 0.78 0.974 (0.939–1.00) 1.11 1.19 0.783 (0.659–0.907)
 17 Use methods to emphasize consequences: 
Positive  effects of quitting, negative  effects 
of not quitting
0.63 0.62 0.855 (0.661–1.00) 1.57 1.62 0.423 (0.010–0.753)
 18 Provide information about health 
consequences of performing the behavior: 
Quitting improves health and saves money
0.24 0.33 0.766 (0.455–1.00) 0.59 0.49 0.865 (0.662–1.00)
 19 Advise on how to avoid exposure: Gradual 
cessation is not effective
0.43 0.53 0.894 (0.716–1.00) 0.35 0.32 0.587 (0.232–0.892)
 20 Advise on how to avoid exposure: Abrupt 
cessation
0.39 0.38 0.796 (0.583–0.948) 0.43 0.30 0.598 (0.255–0.886)
 21 Explain why it is better to stop abruptly: 
Abrupt cessation
0.12 0.18 0.543 (-0.066–1.00) 0.32 0.27 0.473 (0.052–0.895)
 22 Set a quit date: Ask the patient whether they 
want to quit/set a quit date
0.04 0.04 -0.010 (-1.00–0.495) 0.54 0.49 0.651 (0.371–0.930)
 23 Set a quit date: Together with the patient 
suggest to find a quit date
0.04 0.04 1.00 (1.00–1.00) 0.46 0.51 0.723 (0.459–0.925)
 24 Provide information about health consequences: 
Withdrawal symptoms might occur
0.98 0.98 1.00 (1.00–1.00) 0.57 0.54 0.924 (0.819–1.00)
 25 Provide information about health 
consequences: Describe withdrawal symptoms 
and how to handle them
0.90 0.91 0.972 (0.931–1.00) 0.59 0.70 0.907 (0.817–0.974)
Continued
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smoking cessation messages, in general (Figure 
2). ‘Importance of medicine for cure’ and ‘taking 
it regularly’ were implemented in 91.9% (95% 
CI: 78.7–97.2) and 70.3% (95% CI: 54.2–82.5), 
respectively. ‘Emphasizing the positive effects of 
quitting’ was implemented fully in 83.7% (95% CI: 
68.9–92.4) of the sessions. ‘Abstaining from alcohol 
and tobacco’ was advised in almost all of the sessions, 
but this advice was marked as partial. To qualify for 
full implementation, both alcohol and tobacco would 
have to be addressed in this item, whereas in our 
sample alcohol was rarely discussed. Patients were 
asked whether they used tobacco in 70.3% (95% CI: 
54.2–82.5) of sessions, yet a quit date was only set in 
32.4% (95% CI: 19.6–48.5) of sessions.
In the quality of interaction items, building general 
rapport (86.5%, 95% CI: 72.0–94.1), eliciting and 
answering questions (89.2%, 95% CI: 75.3–95.7) and 
providing reassurance (75.7%, 95% CI: 59.9–86.6) 
were implemented well. Contextual tailoring, for 
instance, changing the examples of which foods to eat 
depending on patients’ socioeconomic status, occurred 
in only 16.2% (95% CI: 7.7–31.1) of sessions.  
In Bangladesh, messages consistently not 
implemented were ‘to never take a double dose of 
TB medicine’, ‘to get fresh air as part of a healthy 
lifestyle’, and ‘to refer to the leaflet for further 
information on smoking cessation’.
 In Pakistan, in the National TB control programme 
– (public settings), BS elements relating to TB 
compliance were implemented in 75.5% (95% CI: 
62.4–85.1) of the sessions (Figure 3). Nutrition advice 
was implemented in 73.6% (95% CI: 60.4–83.1) of the 
sessions. Advice on getting help from friends or family 
to not forget medicine was implemented in 39.6% 
(95% CI: 27.6–53.1). Advice on abstaining from all 
tobacco products was implemented in about half of 
the sessions (43.4%, 95% CI: 31.0–56.7). Tobacco use 
status was asked about in 34.0% (95% CI: 22.7–47.4) 
of sessions. Information about withdrawal symptoms 
(49.1%, 95% CI: 36.1–62.1) and how to handle them 
(47.1%, 95% CI: 34.4–60.3) was implemented in 
about half of the sessions.
In the quality of interaction items, building general 
rapport was implemented in 45.3% (95% CI: 32.7–
58.6). Implementation was low for the rest of the 
quality items.
In the private clinic in Pakistan, messages relating 
to TB compliance were implemented in 83.3% 
(95% CI: 43.7–97.0) of the sessions (Figure 4). 
Checking tobacco use status, advising on quitting, 
and providing information on withdrawal symptoms 
were all implemented in 66.7%, (95% CI: 30.0–90.3) 
and advice on management of withdrawal symptoms 
was implemented in 83.3% (95% CI: 43.7–97.1) 
of the sessions. Asking the patient whether they 
wanted to quit was implemented in 50.0% (95% CI: 
18.8–81.2) of the sessions, whilst setting a quit date 
with the patient was only partially implemented in 
33.3% (95% CI: 9.6–70.0) of the sessions. Advice on 
getting family support for both TB medication and 


























 26 Build general rapport 0.75 0.69 0.900 (0.749–1.00) 1.08 0.73 0.232 (-0.174–0.541)
 27 Elicit and answer questions 0.22 0.25 0.733 (0.393–1.00) 0.95 1.24 0.167 (-0.350–0.588)
 28 Provide reassurance 0.10 0.18 0.838 (0.513–1.00) 0.84 0.95 0.582 (0.307–0.800)
 29 Use reflective listening 0.02 0.07 -0.010 (-1.00–0.505) 0.35 0.30 0.059 (-0.417–0.468)
 30 Offer/direct towards written materials 0.00 0.00 0.000 (0.000–0.000) 0.11 0.38 0.376 (-0.123–0.875)
 31 Tailor interactions appropriately 0.00 0.00 0.000 (0.000–0.000) 0.32 0.38 0.724 (0.356–1.00)
Mean Krippendorff’s alpha for Adherence was 0.548 and for Quality was 0.357 for Bangladesh; for Adherence it was 0.846 and for Quality it was 0.410 for Pakistan. The anchors 
for 13 items were 0 (not implemented), 1 (partially implemented), 2 (fully implemented), and for 18 items were 0 or 2. Items in bold show low agreement (i.e. α<0.67). 
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Figure 2. Behavior Support intervention fidelity (Bangladesh)Figure 2. Behaviour Support intervention fidelity (Bangladesh) 
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Item22 Ask the patient whether they want to quit/set a quit date
Item25 Describe withdrawal symptoms and how to handle them
Item24 Withdrawal symptoms might occur
Item23 Together with the patient suggest to find a quit date
Item21 Abrupt cessation
Item26 Build general rapport
Item4 Keep taking medicine even if they have pos or neg effects
Item9 Encourage the patient to adopt a healthy lifestyle
Item20 Advise on how to avoid exposure
Item27 Elicit and answer questions
Item29 Use reflective listening
Item31 Tailor interactions appropriately
Item5 Get help from friends/family not to forget medicine
Item7 Having TB is not shameful
Item10 Abstain from all tobacco products
Item19 Gradual cessation is not effective
Item28 Provide reassurance
Item8 You will need support of family and friends to get better
Item6 Keep coming to scheduled appointments
Item12 Getting lots of rest
Item30 Offer/direct towards written materials
Item14 abstaining from alcohol and tobacco
Item3 Never take a double dose
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Figure 3. Behavior Support intervention fidelity (Pakistan - Public) 
Figure 3. Behaviour Support intervention fidelity (Pakistan - Public)  
 
 
0 10 20 30 40 50 60 70 80 90 100
Item2 Keep taking medicines regularly
Item11 Healthy and nutritious food
Item24 Withdrawal symptoms might occur
Item25 Describe withdrawal symptoms and how to handle them
Item10 Abstain from all tobacco products
Item5 Get help from friends/family not to forget medicine
Item7 Having TB is not shameful
Item13 Getting lots of fresh air
Item12 Getting lots of rest
Item15 Check if patient uses tobacco
Item1 You can be cured of TB with medication
Item17 pos effects of quitting, neg effects of not quitting
Item16 pos and neg effects on TB of quitting tobacco
Item4 Keep taking medicine even if they have pos or neg effects
Item9 Encourage the patient to adopt a healthy lifestyle
Item14 abstaining from alcohol and tobacco
Item26 Build general rapport
Item18 quitting improves health and saves money
Item19 Gradual cessation is not effective
Item21 Abrupt cessation
Item27 Elicit and answer questions
Item8 You will need support of family and friends to get better
Item31 Tailor interactions appropriately
Item3 Never take a double dose
Item6 Keep coming to scheduled appointments
Item20 Advise on how to avoid exposure
Item28 Provide reassurance
Item29 Use reflective listening
Item22 Ask the patient whether they want to quit/set a quit date
Item23 Together with the patient suggest to find a quit date











Fully implemented Partially implemented Not implemented
Research Paper
Tobacco Induced Diseases 
Tob. Induc. Dis. 2021;19(April):24
https://doi.org/10.18332/tid/133054
11
a few cases. Messages on adopting a healthier lifestyle 
83.3% (95% CI: 43.7–97.1), getting lots of rest 33.3% 
(95% CI: 9.7–70.0) and getting fresh air 16.7% (95% 
CI: 3.0–56.4) were only implemented partially. 
In the quality of interaction items, building rapport 
was partially implemented in 83.3% (95% CI: 43.7–
97.1) of the sessions. Providing reassurance and 
tailoring interactions was partially implemented 
in 66.7% (95% CI: 30.0–90.3) of the sessions; 
implementation was negligible for the rest of the items.
Figure 4. Behavior Support intervention fidelity (Pakistan - Private) 
Figure 4. Behaviour Support intervention fidelity (Pakistan - Private)  
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Our findings show that most patients received 
counselling on TB medication adherence and on the 
positive effects of quitting smoking. A healthy lifestyle 
and methods to manage withdrawal symptoms were 
explained, and patients’ smoking status was assessed. 
TB-related messages were consistently delivered 
more proficiently than the smoking cessation-related 
messages. Below we discuss our findings in relation to 
the application of the fidelity index and delivery of the 
intervention, including differences between providers 
and settings. 
Fidelity to behavioral support messages was high 
for the majority of main messages. Fidelity was less 
than anticipated for quality of interaction items, 
discussing a quit date, and handing out a leaflet during 
the session. While provision of the leaflet was not 
audibly recorded in these sessions, it is possible that 
the leaflets were handed out after the recording had 
ended or were available for patients to take at their 
leisure. These findings concur with other smoking 
cessation studies reporting fidelity to delivery of 
intervention activities. For example, setting a quit date 
and offering information leaflets were also found to 
be least implemented in our previous research, which 
might be due to the nature of the activity or exchange 
of information not being captured during the audio-
recording of the session52. It appears that setting a quit 
date was infrequently a component of the recorded 
counselling sessions in the current study. This could 
be a problem as higher quality of goal setting has 
been linked to increased quit success56. On the other 
hand, patients returned frequently to the clinic to 
receive TB medication57, granting the health workers 
multiple opportunities to raise the topic of smoking 
after the initial consultation. It is therefore possible 
that the process of finding a quit date occurs less 
frequently during the initial counselling session and 
more implicitly in the course of the provider-patient 
relationship. In a scoping review on the reporting of 
intervention fidelity in tobacco treatment studies, very 
few studies reported on nonspecific treatment effects 
such as the quality of interaction58. Whether this is 
due to poor implementation or a lack of measurement 
and reporting of the quality of interaction is not yet 
known. 
The process evaluation of the TB & Tobacco 
trial found that time constraints and high patient 
volumes frequently forced health workers to adapt 
the intervention to their needs, by excluding the 
flipbook or by focusing on TB messages and on 
statements about health risks from smoking41. Such 
adaptations can only be captured as absences by 
the fidelity index. Future iterations might include a 
second coding round for emerging constructs, noting 
which additional or different contents were delivered 
by health workers and mapping those to the BCTs. 
Our sample of audio-recordings was collected over 
a period of time to account for fidelity changes over 
time as providers’ proficiency increased. However, the 
final sample per site was too limited (3–5 recordings) 
to draw robust conclusions about individual health 
worker proficiency developments. Future studies 
should ensure a larger sample per site to account for 
temporal changes. 
Another aspect of the fidelity index that can be 
critically assessed is the lack of weighting of individual 
messages. As the intervention was brief, at 15–20 
minutes with 8 pages in the flipbook, all messaging 
was already considered essential. The quality items 
could potentially be further refined and examined 
for their importance in intervention delivery18. For 
instance, in health systems with much authority 
resting on the practitioner59, a reflective listening 
approach with room for patient questions may not be 
as well received as in systems more focused on shared 
decision-making. Our index differentiated between 
several types of quality factors as recommended32,33, 
and future versions of the index could consider 
assigning a weighting approach to individual items. 
The trained health workers were able to deliver 
multiple behavior change techniques in the same 
intervention, yet the messages on TB medication 
adherence and TB-related lifestyle changes were 
provided more proficiently. One likely reason is that 
health workers were reasonably familiar with those 
messages from their daily work, whereas the smoking 
cessation advice was new to them. Sequentially, the 
intervention moved from TB advice to smoking 
cessation advice, which is in line with the flow of the 
TB counselling as part of DOTS and is theory-based 
in moving from general lifestyle advice to specific 
smoking cessation advice42. It is possible that the 
counselling structure was not always followed exactly 
as planned, particularly under time constraints in 
a busy clinic60. We found no evidence for smoking 
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message delivery compromising medication adherence 
messages, which indicates that multiple behavioral 
changes can be advocated for, using our intervention. 
Differences between Pakistan and Bangladesh 
were found in the quality of interaction items and in 
the frequency of setting a quit date. In the Pakistan 
sample, eliciting and answering questions took place 
less frequently than in Bangladesh. One possible 
explanation for these low quality of interaction 
scores in Pakistan could be the limited time available 
for each counselling session. Active listening, posing 
open questions and opening up space for patients 
to talk about their experiences takes time, whereas 
patients may have been waiting for a diagnosis and 
medication for several hours and eager to get back 
home or to work41. The health workers also had a 
higher workload in some of the tertiary care hospitals 
in Pakistan, consisting of the administrative work of 
registering new patients, delivering medication, and 
providing TB counselling61, which can act as a barrier 
to service provision62. They may pragmatically have 
opted for a didactic interaction rather than a two-way 
conversation in order to allow them to see all patients 
waiting within the allotted time. In the private setting 
in Pakistan, setting a quit date was addressed more 
frequently than in the public sector (33.3% vs 3.8% 
of sessions), as was checking for tobacco use. As the 
private setting included only one clinic, this could 
be a site-specific effect illustrating high provider 
motivation, or an artefact of the observation. The 
concept of setting a quit date together with patients 
still needs to be explored further with health workers 
to better understand why this component of the 
intervention was less frequently addressed.  
Limitations
There are several limitations in our study. First, 
potential moderating factors in providers and also 
in patients were not taken into account in this 
assessment. Individual characteristics of the providers 
and patients (e.g. gender, age) may have an effect on 
intervention delivery and quality of interaction63, and 
providers who smoke themselves may be less likely to 
deliver cessation advice64,65. As the intervention was 
provided to all newly diagnosed TB patients entering 
care, it is possible that those whose sessions were 
recorded were non-smokers. In that case, providers 
may have received that information in a different 
way before starting the counselling and their lack of 
addressing smoking status or setting a quit date might 
be their tailoring of the intervention to patient needs. 
The fidelity assessment may need to be complemented 
with additional data sources outside the main 
intervention session to account for such deviations. 
Second, private settings are not well represented in 
this sample as only one such clinic is included. This 
should be considered when interpreting the findings 
of this study in relation to the private healthcare 
context. Finally, sample selection for audio-recording 
was left at the discretion of the providers for flexibility, 
as patient load can be heavy at certain times in the 
outpatient department of public hospitals. The trial 
researchers based at each hospital could have audio-
recorded these patient-provider sessions, which 
might have bypassed the self-selection bias but due 
to patient privacy it was not considered. Moreover, 
presence of an observer may adversely affect patient-
provider rapport building in the intervention sessions 
and it was considered less obtrusive for the providers 
to record their own sessions rather than the presence 
of researchers in the room to facilitate the process.
Research implications 
The fidelity index provides a useful method to 
capture and quantify individual behavioral change 
items, enabling better description of intervention 
activities that were actually delivered during 
practice. Future assessments of multiple behavioral 
change interventions should consider more than 
one data source for fidelity assessment, to allow for 
a complete understanding of the specific context of 
an intervention session. The balance between fidelity 
and adaptation may be an important indicator of 
implementation success66. A larger sample for fidelity 
measurement at each site over a longer period would 
enable researchers to also assess temporal variations 
in delivery, and more information about providers 
and recipients of the intervention would be useful 
to better judge adaptations made by health workers. 
Practice implications
Our fidelity findings indicate that the TB & Tobacco 
behavioral support intervention was implemented 
successfully, and cessation messages were integrated 
into the TB adherence counselling. A future iteration 
of the intervention should consider additional training 
Research Paper
Tobacco Induced Diseases 
Tob. Induc. Dis. 2021;19(April):24
https://doi.org/10.18332/tid/133054
14
on patient rapport-building for health workers. To 
ensure integrity of the intervention, health workers 
could be encouraged to deliver a modified, core 
message programme instead of self-selecting 
messages, when pressed for time. Policymakers 
and TB managers could support the inclusion of an 
integrated tobacco cessation intervention into routine 
care by providing additional resources to separate 
counselling from TB administrative tasks. 
CONCLUSIONS
A smoking cessation behavior support programme 
based on behavior change technique-guided 
counselling and integrated into a TB behavior 
counselling session was examined. Fidelity to the 
intervention delivery was found to be high for TB-
related messages but not for the main smoking 
cessation messages. Clinic contexts may play a 
mediating role in health workers’ opportunities to 
deliver the intervention as planned.
 
REFERENCES
1.  Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith 
KR. Risk of tuberculosis from exposure to tobacco smoke: 
a systematic review and meta-analysis. Arch Intern Med. 
2007;167(4):335-342. doi:10.1001/archinte.167.4.335
2.  World Health Organization. A WHO/The Union 
Monograph on TB and Tobacco Control. Geneva: World 
Health Organization; 2007. https://apps.who.int/iris/
bitstream/handle/10665/43812/9789241596220_eng.
pdf;jsessionid=8594EE38182A51A94CC3ABA285 
F6EDFB?sequence=1. Accessed May 30, 2017.
3.  Nadda JP, Singh PK. New evidence of the tuberculosis burden in 
Asia demands national action. Lancet. 2016;388(10057):2217-
2219. doi:10.1016/S0140-6736(16)31853-0
4.  Reitsma MB, Fullman N, Ng M, et al. Smoking prevalence 
and attributable disease burden in 195 countries and 
territories, 1990–2015: a systematic analysis from the Global 
Burden of Disease Study 2015. Lancet. 2017;389:1885-
1906. doi:10.1016/S0140-6736(17)30819-X
5.  Wang EY, Arrazola RA, Mathema B, Ahluwalia IB, Mase 
SR. The impact of smoking on tuberculosis treatment 
outcomes: A meta-analysis. Int J Tuberc Lung Dis. 
2020;24:170-175. doi:10.5588/ijtld.19.0002
6.  Tachfouti N, Nejjari C, Benjelloun MC, et al. Association 
between smoking status, other factors and tuberculosis 
treatment failure in Morocco. Int J Tuberc Lung Dis. 
2011;15(6). doi:10.5588/ijtld.10.0437
7.  Thomas A, Gopi PG, Santha T, et al. Predictors of relapse 
among pulmonary tuberculosis patients treated in a DOTS 
programme in South India. Int J Tuberc Lung Dis. 2005 
May;9(5). PMID:15875929
8.  Slama K, Chiang CY, Enarson DA, et al. Tobacco and 
tuberculosis: A qualitative systematic review and meta-
analysis. Int J Tuberc Lung Dis. 2007;11(10):1049-1061. 
https://tmu.pure.elsevier.com/en/publications/tobacco-
and-tuberculosis-a-qualitative-systematic-review-and-
meta. Accessed January 3, 2021.
9.  World Health Organization. Global Tuberculosis Report 2018. 
Geneva: World Health Organization; 2018. https://apps.who.
int/iris/bitstream/handle/10665/274453/9789241565646-
eng.pdf?sequence=1&isAllowed=y. Accessed November 6, 
2020
10.  World Health Organization. Tuberculosis profile: 
Bangladesh. Accessed November 6, 2020. https://
wor ldhea l tho rg . sh inyapps . i o / tb_pro f i l e s / ?_
inputs_&entity_type=%22country%22&lan=%22EN% 
22&iso2=%22BD%22
11.  The Tobacco Atlas. Country: Bangladesh. https://
tobaccoatlas.org/country/bangladesh/. Accessed July 1, 
2020.
12.  The Tobacco Atlas. Country: Pakistan. https://
tobaccoatlas.org/country/pakistan/. Accessed July 1, 
2020.
13.  Black N, Johnston M, Michie S, et al. Behavior change 
techniques associated with smoking cessation in 
intervention and comparator groups of randomized 
controlled trials: a systematic review and meta-regression. 
Addiction. 2020;115. doi:10.1111/add.15056
14.  Moore GF, Audrey S, Barker M, et al. Process evaluation 
of complex interventions: Medical Research Council 
guidance. BMJ. 2015;350. doi:10.1136/bmj.h1258
15.  Dane AV, Schneider BH. Program integrity in primary 
and early secondary prevention: Are implementation 
effects out of control? Clin Psychol Rev. 1998;18(1):23-
45. doi:10.1016/S0272-7358(97)00043-3
16.  Prochaska JO. Multiple Health Behavior Research 
represents the future of preventive medicine. Prev Med. 
2008;46:281-285. doi:10.1016/j.ypmed.2008.01.015
17.  Yin HQ, Prochaska JO, Rossi JS, et al. Treatment-
enhanced paired action contributes substantially to 
change across multiple health behaviors: secondary 
analyses of five randomized trials. Transl Behav Med. 
2013;3:62-71. doi:10.1007/s13142-013-0193-4
18.  Thompson TP, Lambert JD, Greaves CJ, Taylor AH. 
Intervention delivery fidelity assessment of a counseling-
based intervention for promoting smoking reduction and 
increasing physical activity. Health Psychol. 2018;37:627-
637. doi:10.1037/hea0000613
19.  Hyman DJ, Pavlik VN, Taylor WC, Goodrick GK, Moye 
L. Simultaneous vs sequential counseling for multiple 
behavior change. Arch Intern Med. 2007;167:1152-1158. 
doi:10.1001/archinte.167.11.1152
20.  King AC, Castro CM, Buman MP, Hekler EB, Urizar 
GG, Ahn DK. Behavioral Impacts of Sequentially 
versus Simultaneously Delivered Dietary Plus Physical 
Activity Interventions: the CALM Trial. Ann Behav Med. 
Research Paper
Tobacco Induced Diseases 




21.  Everson-Hock ES, Taylor AH, Ussher M, Faulkner G. 
A Qualitative perspective on multiple health behavior 
change: Views of smoking cessation advisors who 
promote physical activity. J Smok Cessat. 2010;5:7-14. 
doi:10.1375/jsc.5.1.7
22.  Maddison R, Roberts V, McRobbie H, et al. Exercise 
Counseling to Enhance Smoking Cessation Outcomes: 
The Fit2Quit Randomized Controlled Trial. Ann Behav 
Med. 2014;48:194-204. doi:10.1007/s12160-014-9588-9
23.  Schulz DN, Kremers SPJ, Vandelanotte C, et al. Effects 
of a web-based tailored multiple-lifestyle intervention for 
adults: A two-year randomized controlled trial comparing 
sequential and simultaneous delivery modes. J Med 
Internet Res. 2014;16(1). doi:10.2196/jmir.3094
24.  Aung MN, Yuasa M, Moolphate S, et al. Effectiveness 
of a new multi-component smoking cessation service 
package for patients with hypertension and diabetes 
in northern Thailand: a randomized controlled trial 
(ESCAPE study). Subst Abuse Treat Prev Policy. 2019;14. 
doi:10.1186/s13011-019-0197-2
25.  Thankappan KR, Mini GK, Daivadanam M, Vijayakumar 
G, Sarma PS, Nichter M. Smoking cessation among 
diabetes patients: results of a pilot randomized controlled 
trial in Kerala, India. BMC Public Health. 2013;13. 
doi:10.1186/1471-2458-13-47
26.  Siddiqi  K,  Khan A,  Ahmad M,  et  a l .  Act ion 
to  Stop Smoking in Suspected Tuberculos is 
(ASSIST) in Pakistan. Ann Intern Med. 2013;158. 
doi:10.7326/0003-4819-158-9-201305070-00006
27.  Grimshaw JM, Shirran L, Thomas R, et al. Changing 
provider behavior: an overview of systematic reviews 
of interventions. Med Care. 2001;39(8 Suppl 2):II2-
45. http://www.ncbi.nlm.nih.gov/pubmed/11583120. 
Accessed May 2, 2019.
28.  Durlak JA, DuPre EP. Implementation Matters: A 
Review of Research on the Influence of Implementation 
on Program Outcomes and the Factors Affecting 
Implementation. Am J Community Psychol. 2008;41:327-
350. doi:10.1007/s10464-008-9165-0
29.  Lorencatto F, West R, Bruguera C, Michie S. A method 
for assessing fidelity of delivery of telephone behavioral 
support for smoking cessation. J Consult Clin Psychol. 
2014;82:482-491. doi:10.1037/a0035149
30.  Lennox AS, Bain N, Taylor RJ, McKie L, Donnan PT, 
Groves J. Stages of Change training for opportunistic 
smoking intervention by the primary health care 
team. Part I : randomised controlled trial of the effect 
of training on patient smoking outcomes and health 
professional behavior as recalled by patients. Health Educ 
J. 1998;57:140-149. doi:10.1177/001789699805700206
31.  Hawe P, Shiell A, Riley T. Complex interventions: how 
“out of control” can a randomised controlled trial be? BMJ. 
2004;328:1561-1563. doi:10.1136/bmj.328.7455.1561
32.  Borrelli B, Sepinwall D, Ernst D, et al. A new tool to assess 
treatment fidelity and evaluation of treatment fidelity across 
10 years of health behavior research. J Consult Clin Psychol. 
2005;73:852-860. doi:10.1037/0022-006X.73.5.852
33.  Borrel l i  B.  The Assessment,  Monitoring,  and 
Enhancement of Treatment Fidelity In Public Health 
Clinical Trials. J Public Health Dent. 2011;71:S52-S63. 
doi:10.1111/j.1752-7325.2011.00233.x
34.  Peters D, Tran N, Adam T. Implementation research in 
health: a practical guide. Alliance for Health Policy and 
Systems Research, World Health Organization; 2013.
35.  Carroll C, Patterson M, Wood S, Booth A, Rick J, Balain 
S. A conceptual framework for implementation fidelity. 
Implement Sci. 2007;2. doi:10.1186/1748-5908-2-40
36.  Lorencatto F, West R, Christopherson C, Michie S. 
Assessing fidelity of delivery of smoking cessation 
behavioral support in practice. Implement Sci. 2013;8. 
doi:10.1186/1748-5908-8-40
37.  Hasson H. Systematic evaluation of implementation 
fidelity of complex interventions in health and social care. 
Implement Sci. 2010;5. doi:10.1186/1748-5908-5-67
38.  Geerligs L, Rankin NM, Shepherd HL, Butow P. Hospital-
based interventions: A systematic review of staff-reported 
barriers and facilitators to implementation processes. 
Implement Sci. 2018;13. doi:10.1186/s13012-018-0726-9
39.  Squires JE, Estabrooks CA, Scott SD, et al. The influence 
of organizational context on the use of research by nurses 
in Canadian pediatric hospitals. BMC Health Serv Res. 
2013;13. doi:10.1186/1472-6963-13-351
40.  Dogar O, Elsey H, Khanal S, Siddiqi K. Challenges of 
Integrating Tobacco Cessation Interventions in TB 
Programmes: Case Studies from Nepal and Pakistan. J 
Smok Cessat. 2016;11:108-115. doi:10.1017/jsc.2015.20
41.  Boeckmann M, Warsi S, Noor M, et al. Health worker and 
patient views on implementation of smoking cessation in 
routine tuberculosis care. NPJ Prim Care Respir Med. 
2019;29. doi:10.1038/s41533-019-0146-6
42.  Warsi S, Elsey H, Boeckmann M, et al. Using behavior 
change theory to train health workers on tobacco cessation 
support for tuberculosis patients: a mixed-methods study 
in Bangladesh, Nepal and Pakistan. BMC Health Serv Res. 
2019;19. doi:10.1186/s12913-019-3909-4
43.  Kastaun S, Leve V, Hildebrandt J, et al. Effectiveness 
of training general practitioners to improve the 
implementation of brief stop-smoking advice in German 
primary care: Study protocol of a pragmatic, 2-arm cluster 
randomised controlled trial (the ABCII trial). BMC Fam 
Pract. 2019;20. doi:10.1186/s12875-019-0986-8
44.  Papadakis S, Cole AG, Reid RD, et al. Increasing rates 
of tobacco treatment delivery in primary care practice: 
Evaluation of the Ottawa model for smoking cessation. 
Ann Fam Med. 2016;14:235-243. doi:10.1370/afm.1909
45.  Keyworth C, Epton T, Goldthorpe J, Calam R, Armitage CJ. 
Delivering Opportunistic Behavior Change Interventions: 
a Systematic Review of Systematic Reviews. Prev Sci. 
2020;21:319-331. doi:10.1007/s11121-020-01087-6
Research Paper
Tobacco Induced Diseases 
Tob. Induc. Dis. 2021;19(April):24
https://doi.org/10.18332/tid/133054
16
46.  Cacace M, Ettelt S, Mays N, Nolte E. Assessing quality in 
cross-country comparisons of health systems and policies: 
Towards a set of generic quality criteria. Health Policy. 
2013;112:156-162. doi:10.1016/j.healthpol.2013.03.020
47.  Dogar O, Barua D, Boeckmann M, et al. The safety, 
effectiveness and cost-effectiveness of cytisine in 
achieving six-month continuous smoking abstinence 
in tuberculosis patients - protocol for a double-
blind, placebo-controlled randomised trial. Addiction. 
2018;113(9). doi:10.1111/add.14242
48.  Dogar O, Keding A, Gabe R, et al. Cytisine for 
smoking cessation in patients with tuberculosis: a 
multicentre, randomised, double-blind, placebo-
controlled phase 3 trial. Lancet Glob Health. 2020;8. 
doi:10.1016/S2214-109X(20)30312-0
49.  Wells WA, Uplekar M, Pai M. Achieving Systemic and 
Scalable Private Sector Engagement in Tuberculosis Care 
and Prevention in Asia. PLoS Med. 2015;12:e1001842. 
doi:10.1371/journal.pmed.1001842
50.  Hanson C, Osberg M, Brown J, Durham G, Chin 
DP. Finding the Missing Patients with Tuberculosis: 
Lessons Learned from Patient-Pathway Analyses in 5 
Countries. J Infect Dis. 2017;216(suppl_7):S686-S695. 
doi:10.1093/infdis/jix388
51.  Elsey H, Khanal S, Manandhar S, et al. Understanding 
implementation and feasibility of tobacco cessation in 
routine primary care in Nepal: a mixed methods study. 
Implement Sci. 2015;11. doi:10.1186/s13012-016-0466-7
52.  Dogar O, Boehnke JR, Lorencatto F, Sheldon TA, Siddiqi 
K. Measuring fidelity to behavioral support delivery for 
smoking cessation and its association with outcomes. 
Addiction. 2020;115:368-380. doi:10.1111/add.14804
53.  Siddiqi K, Dogar O, Rashid R, et al. Behavior change 
intervention for smokeless tobacco cessation: its 
development, feasibility and fidelity testing in 
Pakistan and in the UK. BMC Public Health. 2016;16. 
doi:10.1186/s12889-016-3177-8
54.  Michie S, Richardson M, Johnston M, et al. The 
Behavior Change Technique Taxonomy (v1) of 93 
Hierarchically Clustered Techniques: Building an 
International Consensus for the Reporting of Behavior 
Change Interventions. Ann Behav Med. 2013;46:81-95. 
doi:10.1007/s12160-013-9486-6
55.  SAS [computer program]. Version 9.4. Cary, NC: SAS 
Institute.
56.  Lorencatto F, West R, Bruguera C, Brose LS, Michie 
S. Assessing the Quality of Goal Setting in Behavioral 
Support for Smoking Cessation and its Association 
with Outcomes. Ann Behav Med. 2016;50:310-318. 
doi:10.1007/s12160-015-9755-7
57.  World Health Organization. The STOP TB Strategy: 
Building on and enhancing DOTS to meet the TB-related 
Millennium Development Goals. Geneva: World Health 
Organization; 2006.
58.  Salloum RG, Rojewski AM, Piper ME, et al. Reporting 
Treatment Fidelity in Behavioral Tobacco Treatment 
Clinical Trials: Scoping Review and Measurement 
Recommendations. Nicotine Tob Res. Forthcoming 2021.
59.  Claramita M, Nugraheni MDF, van Dalen J, van der 
Vleuten C. Doctor-patient communication in Southeast 
Asia: a different culture? Adv Health Sci Educ Theory 
Pract. 2013;18:15-31. doi:10.1007/s10459-012-9352-5
60.  Westland H, Koop Y, Schröder CD, et al. Nurses’ 
perceptions towards the delivery and feasibility of a 
behavior change intervention to enhance physical activity 
in patients at risk for cardiovascular disease in primary 
care: A qualitative study. BMC Fam Pract. 2018;19. 
doi:10.1186/s12875-018-0888-1
61.  Soomro MH, Qadeer E, Mørkve O. Barriers in the 
management of tuberculosis in Rawalpindi, Pakistan: A 
qualitative study. Tanaffos. 2013;12:28-34. https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC4153264/. Accessed 
November 6, 2020.
62.  Cattamanchi A, Miller CR, Tapley A, et al. Health worker 
perspectives on barriers to delivery of routine tuberculosis 
diagnostic evaluation services in Uganda: A qualitative 
study to guide clinic-based interventions. BMC Health 
Serv Res. 2015;15. doi:10.1186/s12913-014-0668-0
63.  Campbell BK, Buti A, Fussell HE, Srikanth P, Mccarty 
D, Guydish JR. Therapist predictors of treatment 
delivery fidelity in a community-based trial of 12-step 
facilitation. Am J Drug Alcohol Abuse. 2013;39:304-311. 
doi:10.3109/00952990.2013.799175
64.  Abdullah AS, Stillman FA, Yang L, Luo H, Zhang Z, 
Samet JM. Tobacco use and smoking cessation practices 
among physicians in developing countries: A literature 
review (1987-2010). Int J Environ Res Public Health. 
2013;11:429-455. doi:10.3390/ijerph110100429
65.  Mohan S, Pradeepkumar AS, Thresia CU, et al. 
Tobacco use among medical professionals in Kerala, 
India: The need for enhanced tobacco cessation and 
control efforts. Addict Behav. 2006;31:2313-2318. 
doi:10.1016/j.addbeh.2006.02.013
66.  Toomey E, Hardeman W, Hankonen N, et al. Focusing 
on fidelity: narrative review and recommendations for 
improving intervention fidelity within trials of health 
behavior change interventions. Health Psychol Behav Med. 
2020;8:132-151. doi:10.1080/21642850.2020.1738935 
ACKNOWLEDGEMENTS
The authors thank all the study participants who gave consent to 
have the behavior support session recorded. We acknowledge the 
important work of Maryam Noor, Saleem, Sheryar, Fariza Fieroze and 
Lina Silwa who coded the fidelity indices. Dominic Hart entered data 
for Bangladesh. We thank Helen Elsey and Sahil Warsi for giving input 
to first drafts of the fidelity index. The work was conducted while MB 
was based at the Medical Faculty of the Heinrich-Heine-University 
Duesseldorf, Institute of General Practice, Addiction Research and 
Epidemiology Unit. We would like to acknowledge Anne Readshaw for 
proofreading the manuscript.
Research Paper
Tobacco Induced Diseases 
Tob. Induc. Dis. 2021;19(April):24
https://doi.org/10.18332/tid/133054
17
CONFLICTS OF INTEREST 
The authors have each completed and submitted an ICMJE form for 
disclosure of potential conflicts of interest. The authors declare that 
they have no competing interests, financial or otherwise, related to 
the current work. K. Siddiqi reports grants from European Commission 
H2020, and non-financial support from Aflofarm, during the conduct 
of the study. D. Kotz reports that he received an unrestricted grant from 
Pfizer in 2009 for an investigator-initiated trial on the effectiveness 
of practice nurse counselling and varenicline for smoking cessation in 
primary care (Dutch Trial Register NTR3067; DOI: 10.1111/add.13927). 
FUNDING
The TB & Tobacco project received funding from the European Union’s 
Horizon 2020 Research and Innovation programme, under Grant 
Agreement No. 680995. The European Commission is not responsible 
for the contents of this article. The authors have not entered into 
an agreement with the funder that may have limited their ability to 
complete the research as planned. The authors had full control of all 
primary data. The funding body had no role in design of the study 
and collection, analysis, and interpretation of data and in writing the 
manuscript. Aflofarm Pharma Poland provided cytisine and placebo for 
the trial free of charge. The provider of cytisine had no role in designing 
or conducting the study, or in preparing this manuscript.
AUTHORS’ CONTRIBUTIONS
MB designed the fidelity index, index training, conducted the 
training, prepared data for analysis, interpreted findings and wrote 
the manuscript. OD contributed to the fidelity index development, 
index training materials, conducted the analyses, interpreted findings 
and co-wrote the manuscript. SSw tested the fidelity index coding 
and contributed to the writing of the manuscript. AK led the fidelity 
coding in Pakistan and contributed to the writing of the manuscript. KS 
contributed to index development and writing of the manuscript. DK 
designed the process evaluation and fidelity assessment together with 
MB, led the overall process evaluation, helped interpret the findings and 
contributed to the writing of the manuscript.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
